The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients
The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients
Background: death from sepsis in the intensive therapy unit (ITU) is frequently preceded by the development of multiple organ failure as a result of uncontrolled inflammation. Treatment with omega-3 (n-3) fatty acids (FAs), principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has been demonstrated to attenuate the effects of uncontrolled inflammation and may be clinically beneficial in reducing mortality from organ dysfunction. Fish oil (FO) is a source of EPA and DHA.
Methods: a randomized trial investigating the effects of parenteral (intravenous) nutrition providing FO (0.092 g EPA+DHA/kg body weight/day) was conducted. Sixty consecutive ITU patients diagnosed with sepsis were randomised to receive either once daily parenteral FO and standard medical care or standard medical care only.
Results: forty one patients (21 received fish oil; 20 controls) consented to blood sampling and blood was taken on days 0, 1, 2, 3, 5, 7, 10 and 13; because of deaths, patient discharge and withdrawal of consent, the number of blood samples available for analysis diminished with time. FA composition of plasma phosphatidylcholine (PC), plasma non-esterified FAs (NEFAs) and peripheral blood mononuclear cells (PBMCs) was determined by gas chromatography. EPA and DHA were rapidly in corporated into all 3 lipid pools investigated. There was a reduction in the arachidonic acid (AA) to EPA+DHA ratio in plasma PC and NEFAs. Fewer patients died in the FO group (13.3% (n=4)) compared with the control group (26.7% (n=8)) but this difference was not significant. A reduction in the AA/(EPA+DHA) ratio in PBMCs and plasma PC was associated with significantly improved survival. Plasma PC, plasma NEFA and PBMC FA profiles are rapidly altered by FO infusion in critically ill septic patients.
Conclusion: the provision of high dose n-3 FAs resulted in a rapid and significant increase in EPA and DHA and a reduction in AA/(EPA+DHA) ratio. This latter reduction is associated with improved survival
sepsis, intensive care unit, intensive therapy unit, fish oil, omega-3, fatty acids
1-11
Hall, T.C.
5bbafb05-8a1e-4642-a833-958406605acb
Bilku, D.K.
2680204f-fa69-4f5e-9d3f-189f8a698785
Neal, C.P.
44efc582-3fdd-4557-97a0-8605a9663dfd
Cooke, J.
29836b43-6a68-4b57-a6e0-c819ee2718a2
Fisk, H.
38c7f1f0-5dfc-4f71-aa0f-ec4f0e5839f3
Calder, P.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Dennison, A.R.
038c0e5c-a734-48e6-a85b-97e7c5b266c1
29 July 2016
Hall, T.C.
5bbafb05-8a1e-4642-a833-958406605acb
Bilku, D.K.
2680204f-fa69-4f5e-9d3f-189f8a698785
Neal, C.P.
44efc582-3fdd-4557-97a0-8605a9663dfd
Cooke, J.
29836b43-6a68-4b57-a6e0-c819ee2718a2
Fisk, H.
38c7f1f0-5dfc-4f71-aa0f-ec4f0e5839f3
Calder, P.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Dennison, A.R.
038c0e5c-a734-48e6-a85b-97e7c5b266c1
Hall, T.C., Bilku, D.K., Neal, C.P., Cooke, J., Fisk, H., Calder, P. and Dennison, A.R.
(2016)
The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
Prostaglandins, Leukotrienes and Essential Fatty Acids, 112, .
(doi:10.1016/j.plefa.2016.07.001).
(PMID:27637335)
Abstract
Background: death from sepsis in the intensive therapy unit (ITU) is frequently preceded by the development of multiple organ failure as a result of uncontrolled inflammation. Treatment with omega-3 (n-3) fatty acids (FAs), principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has been demonstrated to attenuate the effects of uncontrolled inflammation and may be clinically beneficial in reducing mortality from organ dysfunction. Fish oil (FO) is a source of EPA and DHA.
Methods: a randomized trial investigating the effects of parenteral (intravenous) nutrition providing FO (0.092 g EPA+DHA/kg body weight/day) was conducted. Sixty consecutive ITU patients diagnosed with sepsis were randomised to receive either once daily parenteral FO and standard medical care or standard medical care only.
Results: forty one patients (21 received fish oil; 20 controls) consented to blood sampling and blood was taken on days 0, 1, 2, 3, 5, 7, 10 and 13; because of deaths, patient discharge and withdrawal of consent, the number of blood samples available for analysis diminished with time. FA composition of plasma phosphatidylcholine (PC), plasma non-esterified FAs (NEFAs) and peripheral blood mononuclear cells (PBMCs) was determined by gas chromatography. EPA and DHA were rapidly in corporated into all 3 lipid pools investigated. There was a reduction in the arachidonic acid (AA) to EPA+DHA ratio in plasma PC and NEFAs. Fewer patients died in the FO group (13.3% (n=4)) compared with the control group (26.7% (n=8)) but this difference was not significant. A reduction in the AA/(EPA+DHA) ratio in PBMCs and plasma PC was associated with significantly improved survival. Plasma PC, plasma NEFA and PBMC FA profiles are rapidly altered by FO infusion in critically ill septic patients.
Conclusion: the provision of high dose n-3 FAs resulted in a rapid and significant increase in EPA and DHA and a reduction in AA/(EPA+DHA) ratio. This latter reduction is associated with improved survival
Text
__soton.ac.uk_ude_PersonalFiles_Users_lce_mydocuments_Eprints - Prof Calder_Accepted publications for eprints_PLEFA manuscript revision_ TH_PC.pdf
- Accepted Manuscript
More information
Accepted/In Press date: 8 July 2016
e-pub ahead of print date: 14 July 2016
Published date: 29 July 2016
Keywords:
sepsis, intensive care unit, intensive therapy unit, fish oil, omega-3, fatty acids
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 397914
URI: http://eprints.soton.ac.uk/id/eprint/397914
PURE UUID: 17d371ca-5df5-46d8-ac93-2a46d914244c
Catalogue record
Date deposited: 11 Jul 2016 10:48
Last modified: 15 Mar 2024 05:43
Export record
Altmetrics
Contributors
Author:
T.C. Hall
Author:
D.K. Bilku
Author:
C.P. Neal
Author:
J. Cooke
Author:
H. Fisk
Author:
A.R. Dennison
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
